The effectiveness of the use of a specialized formula based on hydrolyzed milk protein in children older than 1 year of age with cystic fibrosis

Introduction. Malabsorption syndrome is one of the most common manifestations of intestinal insufficiency in cystic fibrosis (CF). CF being the cause of protein-energy malnutrition, so diet therapy using specialized enteral nutrition products is an integral part of CF complex treatment.

Purpose. Evaluation of the tolerability and effectiveness of the domestic specialized semi-elemental formula based on hydrolyzed milk protein «NUTRIEN® Elemental» in the treatment of protein-energy malnutrition in CF children older than 1 year of age with malab-sorption syndrome.

Materials and methods. Under supervision were 32 CF one year 3 months to 17-year children with a mixed form of the disease and malnutrition. Twelve (38%) children had hypolactasia. Nutritional status was assessed using the WHO-Anthro for 1–5-year children  and WHO-Anthro Plus for patients over 5 years of age) programs, and indices of clinical and biochemical blood tests. The average du-ration of follow-up was 21 day. Statistical processing was performed using «Statistica 6.0» («StatSoft Inc.», USA) and Microsoft Excel 2010.

Results. While taking a specialized product, there was a decrease in the number of patients with severe and moderate forms of protein-energy malnutrition, a significant upward trend in such biochemical markers of nutritional status as prealbumin (p < 0.01), transferrin (p < 0.01), total protein (p < 0.01).

Conclusion. The use of a domestic specialized product based on hydrolyzed milk protein «NUTRIEN® Elemental» in the diet therapy of sick children with malabsorption syndrome, including CF patients, indicates its positive effect on the indices of the nutritional status of patients and the course of the underlying disease.

Conflict of interest. The authors declare no conflict of interest.

Acknowledgement. The study had no sponsorship.

Received: January 27, 2022
Accepted:  February 17, 2022
Published: March 15, 2022

1. Konstan M.W., Pasta D.J., VanDevanter D.R., Wagener J.S., Morgan W.J. Epidemiologic Study of Cystic Fibrosis: 25 years of observational research. Scientific Advisory Group and the Investigators and Coordinators of ESCF. Pediatr Pulmonol. 2021; 56(5): 823–36. https://doi.org/10.1002/ppul.25248

2. Bell S.C., Mall M.A., Gutierrez H., Macek M., Madge S., Davies J.C., et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020; 8(1): 65–124. https://doi.org/10.1016/S2213-2600(19)30337-6

3. Bergeron C., Cantin A.M. Cystic Fibrosis: Pathophysiology of Lung Disease. Semin Respir Crit Care Med. 2019; 40(6): 715–26. https://doi.org/10.1055/s-0039-1694021

4. Li L., Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig Liver Dis. 2014; 46: 865–74. https://doi.org/10.1016/j.dld.2014.06.011

5. Munk A. Cystic Fibrosis: evidence for gut inflammation. Int J Biochem Cell Biol. 2014; 52: 180–3. https://doi.org/10.1016/j.biocel.2014.02.005

6. Roslavtseva E.A., Sokolov I., Simonova O.I., Bushueva T.V., Borovik T.E., Smirnov I.E., et al. Diagnostic possibilities of lactase deficiency in children with cystic fibrosis. Rossiyskiy pediatricheskiy zhurnal. 2021; 24(3): 157–62. https://doi.org/10.46563/1560-9561-2021-24-3-157-162

7. Roslavtseva E.A., Bushueva T.V., Borovik T.E., Simonova O.I., Burkina N.I., Lokhmatov M.M. The possibilities of using the domestic mixture for enteral nutrition in the correction of the undernutrition in cystic fibrosis children. Rossiyskiy pediatricheskiy zhurnal. 2019; 22(2): 75–80. https://doi.org/10.18821/1560-9561-2019-22-2-75-80

8. Ratchford T.L., Teckman J.H., Patel D.R. Gastrointestinal pathophysiology and nutrition in cystic fibrosis. Expert Rev Gastroenterol Hepatol. 2018; 12(9): 853–62. https://doi.org/10.1080/17474124.2018.1502663

9. Bushueva T.V., Borovik T.E., Roslavtseva E.A., Simonova O.I., Burkina N.I., Lyabina N.V., etc. Nutritional support for cystic fibrosis: the experience of the introduction of domestic specialized enteral nutrition mixtures. Rossiyskiy pediatricheskiy zhurnal. 2020; 23(1): 13–20. https://doi.org/10.18821/1560-9561-2020-23-1-13-20

10. Project. National Consensus «Cystic fibrosis: definition, diagnostic criteria, therapy» 2018. [Proekt. Natsional’nyy konsensus «Mukovistsidoz: opredelenie, diagnosticheskie kriterii, terapiya» 2018.]. Ed. E.I. Kondrat’eva, N.Yu. Kashirskaya, N.I. Kapranov. Moscow: OOO BORGES Company LLC; 2019. https://mukoviscidoz.org/doc/konsensus/2019/konsensus_2019.pdf